You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 00378-8200


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00378-8200

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00378-8200

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what an NDC is and its components. The National Drug Code (NDC) is a unique 10-digit, three-segment number assigned to medication in the United States. It identifies the labeler, product, and trade package size of the drug[1][4].

  • Labeler Code: Assigned by the FDA, this segment identifies the firm that manufactures or distributes the drug.
  • Product Code: Identifies the specific strength, dosage form, and formulation of the drug for a particular firm.
  • Package Code: Identifies the package sizes and types.

Identifying the Drug

The NDC 00378-8200 can be broken down as follows:

  • Labeler Code: 00378
  • Product Code: 820
  • Package Code: 0

This NDC would correspond to a specific drug product, including its strength, dosage form, and packaging.

Market Trends in the Pharmaceutical Industry

To project the market and price trends for this drug, we need to consider broader industry trends.

Growth and Innovation

The pharmaceutical industry, particularly the biopharma and biotech sectors, is experiencing rapid growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[2].

Regulatory Landscape

The regulatory landscape is evolving to keep pace with innovation. This includes changes in clinical trial designs, increased focus on precision medicine, and the integration of AI and ML technologies. These advancements are likely to impact the pricing and accessibility of drugs[2].

Pricing and Access

Pricing and access to drugs remain significant issues for the life sciences industry. Nearly half of C-suite executives expect pricing and access to significantly affect their strategies in 2025. This trend is influenced by competition from generic drugs and biosimilars, as well as the looming patent cliff, which could impact the pricing of high-revenue products[5].

Specific Market Analysis for NDC 00378-8200

Drug Classification and Market

To provide a detailed analysis, we need to know the specific drug associated with the NDC 00378-8200. However, without this information, we can still discuss general factors that influence drug pricing and market trends.

  • Therapeutic Area: The market size and growth rate of the therapeutic area in which the drug is classified can significantly impact its pricing. For example, the market for Myelodysplastic Syndrome (MDS) drugs is projected to grow from $2.2 billion in 2023 to $4.1 billion by 2030, driven by increasing incidence rates and advancements in treatment options[3].

  • Competition: The presence of generic drugs and biosimilars can reduce the market price of branded drugs. As more patents expire, the competition from generics and biosimilars is expected to increase, potentially affecting the pricing of the drug associated with NDC 00378-8200[5].

  • Regulatory and Clinical Trial Impacts: Changes in clinical trial designs and regulatory approvals can influence the cost and pricing of drugs. Accelerated clinical trial designs and the use of precision medicine could lead to more efficient and cost-effective drug development processes[2].

Price Projections

Pricing Standards

The pricing of drugs identified by NDCs is based on several standards, including the Average Wholesale Price (AWP), the Wholesale Acquisition Cost (WAC), and the Average Sales Price (ASP). These standards help in calculating reimbursement rates and can vary based on market conditions and regulatory changes[1].

Market Dynamics

Given the broader industry trends, here are some potential price projection scenarios:

  • Stable Pricing: If the drug is in a therapeutic area with stable demand and minimal competition from generics or biosimilars, its price might remain relatively stable.

    "We are full of expectations for personalized medicine... With advances in genomics and biomarkers, we can provide patients with more precise treatment options. This not only improves efficacy but also significantly reduces side-effects, allowing patients to have a better treatment experience."[5]
  • Price Reduction: If the drug faces increased competition from generics or biosimilars, or if there are significant advancements in treatment options within its therapeutic area, its price could decrease.

  • Price Increase: If the drug is part of a therapeutic area with high demand and limited competition, or if there are significant regulatory or clinical trial costs associated with its development, its price could increase.

Key Takeaways

  • NDC Importance: The NDC is crucial for identifying and billing drugs accurately, ensuring correct payment and control of drug costs.
  • Industry Trends: The pharmaceutical industry is driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care.
  • Pricing Factors: Pricing is influenced by competition from generics and biosimilars, regulatory changes, and the therapeutic area in which the drug is classified.
  • Market Growth: The biopharma and biotech sectors are experiencing significant growth, with projected CAGRs indicating a robust market.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique 10-digit, three-segment number assigned to medication in the United States, identifying the labeler, product, and trade package size.
  2. How are NDCs numbered?

    • NDCs are numbered in a 3-segment format: the labeler code, product code, and package code, each assigned by the FDA or the firm.
  3. Why are NDCs important for coders and billers?

    • NDCs help ensure correct payment and control of drug costs by accurately identifying the drugs administered and billed.
  4. What factors influence the pricing of drugs in the pharmaceutical industry?

    • Pricing is influenced by competition from generics and biosimilars, regulatory changes, therapeutic area demand, and clinical trial costs.
  5. How do industry trends impact the market for specific drugs?

    • Industry trends such as technological advancements, evolving regulatory frameworks, and shifts towards patient-centered care can significantly impact the market size and pricing of specific drugs.

Sources

  1. https://www.aapc.com/codes/ndc-lookup/
  2. https://tfscro.com/resources/5-predictions-for-the-biopharma-and-biotech-industries-in-2025/
  3. https://www.globenewswire.com/news-release/2024/12/24/3001624/0/en/Myelodysplastic-Syndrome-MDS-Drugs-Market-Trends-and-Sales-Forecast-to-2030-Total-Revenues-to-Reach-US-4-1-Billion-Worldwide-with-Immunomodulatory-Drugs-Dominating-Shares.html
  4. https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information
  5. https://www2.deloitte.com/us/en/insights/industry/health-care/life-sciences-and-health-care-industry-outlooks/2025-life-sciences-executive-outlook.html

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.